Allegis Investment Advisors LLC boosted its position in CVS Health Corporation (NYSE:CVS) by 6.3% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 10,737 shares of the pharmacy operator’s stock after buying an additional 641 shares during the period. Allegis Investment Advisors LLC’s holdings in CVS Health Corporation were worth $1,014,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. MU Investments Co. Ltd. boosted its position in CVS Health Corporation by 62.0% in the second quarter. MU Investments Co. Ltd. now owns 1,150 shares of the pharmacy operator’s stock worth $109,000 after buying an additional 440 shares during the last quarter. Springbok Capital Management LLC boosted its position in CVS Health Corporation by 190.5% in the first quarter. Springbok Capital Management LLC now owns 1,130 shares of the pharmacy operator’s stock worth $117,000 after buying an additional 741 shares during the last quarter. Alexandria Capital LLC boosted its position in CVS Health Corporation by 3.4% in the second quarter. Alexandria Capital LLC now owns 1,405 shares of the pharmacy operator’s stock worth $135,000 after buying an additional 46 shares during the last quarter. Arcadia Investment Management Corp MI boosted its position in CVS Health Corporation by 87.7% in the second quarter. Arcadia Investment Management Corp MI now owns 1,605 shares of the pharmacy operator’s stock worth $154,000 after buying an additional 750 shares during the last quarter. Finally, Cypress Capital Management LLC WY purchased a new position in CVS Health Corporation during the second quarter worth approximately $164,000. 80.96% of the stock is currently owned by institutional investors and hedge funds.

Shares of CVS Health Corporation (NYSE:CVS) traded down 0.258% during midday trading on Wednesday, reaching $89.758. 4,148,731 shares of the company’s stock were exchanged. The company has a market capitalization of $95.70 billion, a PE ratio of 20.648 and a beta of 0.84. The firm has a 50-day moving average of $94.64 and a 200-day moving average of $97.97. CVS Health Corporation has a 1-year low of $86.50 and a 1-year high of $106.67.

CVS Health Corporation (NYSE:CVS) last issued its earnings results on Tuesday, August 2nd. The pharmacy operator reported $1.32 EPS for the quarter, topping the consensus estimate of $1.30 by $0.02. The firm earned $43.70 billion during the quarter, compared to analysts’ expectations of $44.28 billion. CVS Health Corporation had a return on equity of 15.86% and a net margin of 2.88%. CVS Health Corporation’s quarterly revenue was up 17.6% compared to the same quarter last year. During the same period last year, the business earned $1.19 earnings per share. Equities analysts expect that CVS Health Corporation will post $5.86 earnings per share for the current fiscal year.

A number of research analysts have recently commented on CVS shares. Leerink Swann reissued a “buy” rating on shares of CVS Health Corporation in a research report on Friday, June 10th. Credit Suisse Group AG restated a “buy” rating and issued a $115.00 price target on shares of CVS Health Corporation in a research note on Sunday, June 5th. Jefferies Group restated a “buy” rating on shares of CVS Health Corporation in a research note on Monday, July 4th. Mizuho restated a “buy” rating and issued a $108.00 price target (down previously from $117.00) on shares of CVS Health Corporation in a research note on Thursday, June 23rd. Finally, Argus restated a “buy” rating and issued a $120.00 price target on shares of CVS Health Corporation in a research note on Thursday, August 4th. Six equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $113.02.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

5 Day Chart for NYSE:CVS

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.